BAK Immune Cell Therapy: Research Focused on HLA-I Negative Cancer Cells
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
BAK therapy (BRM Activated Killer) is an immune cell therapy focused on activating and expanding "CD56-positive cells" within a patient's body. A feature of this approach is that it targets cancer cells that may evade conventional T-cell recognition; actual effects vary by individual.
Core Principles of BAK Therapy
Traditional CTL (Cytotoxic T Lymphocyte) and Dendritic Cell (DC) therapies rely heavily on HLA-I (Major Histocompatibility Complex Class I) molecules on the surface of cancer cells for identification. However, many advanced cancer cells evolve mechanisms to reduce or stop the expression of HLA-I, thereby escaping T-cell detection.
BAK therapy is designed to address this challenge through the following mechanisms:
- Activation of CD56-Positive Cells: Primarily proliferates NK cells and γδ T cells, which can identify and kill foreign substances without relying on HLA-I.
- Multiple Cell Types: In addition to NK and γδ T cells, the culture process includes CTLs and helper T cells.
- Cell Expansion: Using the patented serum-free AlyS-BAK culture medium, cells are expanded to approximately 10 billion.
Patented Technology and Safety
- Patented Culture Medium: The AlyS-BAK culture medium does not contain human or animal serum, which is intended to reduce the risk of infection from exogenous viruses or bacteria.
- Cytokine Induction: Induction by cytokines such as IFN-α and IL-2 is intended to increase the activity of immune cells; actual effects vary by individual and must be assessed by a physician.
Medical Institution: Akasaka AA Clinic (Tokyo)
BAK therapy is primarily implemented at the "Akasaka AA Clinic," located in Minato-ku, Tokyo. The clinic is led by physicians working in personalized medicine and, in addition to tumor immunotherapy, also offers high-dose Vitamin C and ozone therapy. Suitability is assessed by a physician.
[Medical Supporter Compliance Statement] Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free (initial direction only; further services are quoted separately); an advisor will help you clarify the next steps.